首页> 外国专利> substituted 3 - diphenyl - 1,2,4 - triazoles and their verwenung as pharmazeutischemetallchelatoren

substituted 3 - diphenyl - 1,2,4 - triazoles and their verwenung as pharmazeutischemetallchelatoren

机译:取代3-二苯基-1,2,4-三唑及其药学上的药学要求。

摘要

The use is claimed of substituted 3,5-diphenyl-1,2,4-triazole derivatives of formula (I), or their salts, for treating diseases which cause an excess of metal in the body, or are caused by it. R1, R5 = H, halo, OH, 1-7C alkyl, halo-(1-7C alkyl), 1-7C alkoxy, halo-(1-7C alkoxy), carboxyl, carbamoyl, N-(1-7C alkyl)carbamoyl, N,N-di(1-7C alkyl)carbamoyl or CN; R2, R4 = H, optionally substituted 1-7C alkanoyl or aroyl, or a radical which can be removed under physiological conditions; R3 = H, 1-7C alkyl, hydroxy-(1-7C alkyl), halo-(1-7C alkyl), carboxy-(1-7C alkyl), 1-7C alkoxycarbonyl-(1-7C alkyl), R6R7NC(O)(1-7C alkyl), optionally substituted aryl or aryl-(1-7C alkyl), or optionally substituted heteroaryl or hetero-aralkyl; R6, R7 = H, 1-7C alkyl, hydroxy-(1-7C alkyl), alkoxy-(1-7C alkyl), hydroxyalkoxy(1-7C alkyl), amino-(1-7C alkyl), N-(1-7C alkyl)amino-(1-7C alkyl), N,N-di(1-7C alkyl)amino-(1-7C alkyl), N(hydroxy-(1-7C alkyl))amino-(1-7C alkyl) or N,N-di(hydroxy-(1-7C alkyl))amino-(1-7C alkyl); or NR6R7 = an aza-alicyclic ring. Also claimed are new compounds (IA), i.e. (I) where R3 = R6R7N-C(O)-(1-7C alkyl), optionally substituted aryl, aryl-(1-7C alkyl), substituted by N-(1-7C alkyl)amino, N,N-di(1-7C alkyl)amino or pyrrolidino, or optionally substituted heteroaryl or hetero-aralkyl; provided that R3 is not Ph or Ph substituted by halo, NO2, CN, OH, 1-7C alkyl, halo-(1-7C alkyl), 1-7C alkoxy or 1-7C alkoxycarbonyl if R2 and R4 are H, and R1 and R5 are H, halo, 1-7C alkyl, halo-(1-7C alkyl), 1-7C alkoxy or CN.
机译:要求保护式(I)的取代的3,5-二苯基-1,2,4-三唑衍生物或其盐用于治疗引起体内金属过量或由其引起的疾病的用途。 R1,R5 = H,卤素,OH,1-7C烷基,卤素-(1-7C烷基),1-7C烷氧基,卤素-(1-7C烷氧基),羧基,氨基甲酰基,N-(1-7C烷基)氨基甲酰基,N,N-二(1-7C烷基)氨基甲酰基或CN; R 2,R 4 = H,任选取代的1-7C链烷酰基或芳酰基,或可在生理条件下除去的基团; R3 = H,1-7C烷基,羟基-(1-7C烷基),卤素-(1-7C烷基),羧基-(1-7C烷基),1-7C烷氧羰基-(1-7C烷基),R6R7NC( O)(1-7C烷基),任选取代的芳基或芳基-(1-7C烷基)或任选取代的杂芳基或杂芳烷基; R 6,R 7 = H,1-7C烷基,羟基-(1-7C烷基),烷氧基-(1-7C烷基),羟基烷氧基(1-7C烷基),氨基-(1-7C烷基),N-(1 -7C烷基)氨基-(1-7C烷基),N,N-二(1-7C烷基)氨基-(1-7C烷基),N(羟基-(1-7C烷基))氨基-(1-7C烷基)或N,N-二(羟基-(1-7C烷基))氨基-(1-7C烷基);或NR6R7 =氮杂脂环族环。还要求保护的是新化合物(IA),即(I),其中R3 = R6R7N-C(O)-(1-7C烷基),任选取代的芳基,芳基-(1-7C烷基),被N-(1- 7C烷基)氨基,N,N-二(1-7C烷基)氨基或吡咯烷基,或任选取代的杂芳基或杂芳烷基;前提是如果R2和R4为H,且R1不为Ph或Ph未被卤素或卤素,NO2,CN,OH,1-7C烷基,卤素-(1-7C烷基),1-7C烷氧基或1-7C烷氧羰基取代R 5和R 5是H,卤素,1-7C烷基,卤素-(1-7C烷基),1-7C烷氧基或CN。

著录项

  • 公开/公告号DE69716602D1

    专利类型

  • 公开/公告日2002-11-28

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG BASEL;

    申请/专利号DE19976016602T

  • 发明设计人 LATTMANN RENE;ACKLIN PIERRE;

    申请日1997-06-24

  • 分类号A61K31/41;A61P39/04;C07D249/08;A61K31/185;

  • 国家 DE

  • 入库时间 2022-08-21 23:39:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号